Workflow
Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement

Core Viewpoint - Avalon GloboCare Corp. and YOOV Group Holding Limited have announced a proposed merger, aiming to create a publicly-traded company focused on AI-driven business automation solutions [1][2]. Company Overview - Avalon GloboCare Corp. is a commercial-stage company specializing in precision diagnostic consumer products and cellular therapy, currently marketing the KetoAir™ breathalyzer device, which is registered as a Class I medical device with the U.S. FDA [6]. - YOOV Group Holding Limited is an AI-as-a-Service platform that specializes in intelligent business automation, allowing businesses to optimize operations without extensive resources or technical expertise [4]. Merger Details - The merger involves Nexus MergerSub Limited, a wholly owned subsidiary of Avalon, merging with YOOV, with YOOV becoming a wholly owned subsidiary of Avalon [2]. - The merger is subject to stockholder approval from Avalon and the Nasdaq Stock Market's approval for YOOV's listing post-merger [3]. Additional Offerings - YOOV extends its services into financial and insurance sectors through subsidiaries YOOV Capital Limited and YOOV Insurance Services Limited, enhancing its ecosystem with credit evaluation and insurance brokerage services [5].